🔎 Trials Near Me

Akèy › Obèsite › Illinois › Chicago

Etid klinik pou Obèsite nan Chicago, IL

42 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Ap rekriteFaz 2
  • Charter Research LLC - Chicago, Chicago
  • Flourish Research - Chicago, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07685808

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Ap rekriteFaz 2
  • Great Lakes Clinical Trials - West Wilson Avenue /ID# 282378, Chicago
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07752979

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Ap rekriteFaz 3
  • Great Lakes Clinical Trials, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07720271

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Ap rekriteFaz 3
  • Cedar Crosse Research Center, Chicago
  • Northwestern University, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07595549

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Ap rekriteFaz 3
  • Chicago Research Center, Inc, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07668414

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Ap rekriteFaz 3
  • Ann and Robert Lurie Children's Hospital of Chicago, Chicago
  • University of Illinois at Chicago, Chicago
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Ap rekriteFaz 3
  • Rush University Medical Center, Chicago
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937086

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Ap rekriteFaz 3
  • Rush University Medical Center, Chicago
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937099

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee

Ap rekriteFaz 3
  • Northwestern University, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07153471

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Ap rekriteFaz 3
  • Eagle Clinical Research, Chicago
  • University of Chicago, Chicago
Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Ap rekriteFaz 3
  • Great Lakes Clinical Trials - Ravenswood, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07353931

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Ap rekriteFaz 3
  • Research Site, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Ap rekriteFaz 2
  • Great Lakes Clinical Trials - Ravenswood, Chicago
Laj 18 a 75 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589608

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Ap rekriteFaz 3
  • Great Lakes Clinical Trials - Ravenswood, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07392190

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Ap rekriteFaz 2
  • Great Lakes Clinical Trials - Ravenswood, Chicago
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Ap rekriteFaz 3
  • Flourish Research - Great Lakes Clinical Trials, Chicago
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684235

BRIDGE & Friends Trial

Ap rekriteVolontè an sante akeyi
  • University of Illinois Chicago, Chicago
Laj 50 a 79 · Tout sèks · Mizajou Sep 1, 2026 · NCT07798557

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

Ap rekriteFaz 3
  • Kailera Clinical Site, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07284979

Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.

Ap rekriteVolontè an sante akeyi
  • Illinois Institute of Technology, Chicago
Laj 21 a 74 · Tout sèks · Mizajou Aug 27, 2026 · NCT07566325

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Ap rekriteFaz 3
  • Research Site, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT07784725

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Ap rekriteFaz 2
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Laj 7 a 25 · Tout sèks · Mizajou Aug 19, 2026 · NCT05082519

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Ap rekriteFaz 3
  • Chicago Clinical Research Institute INC, Chicago
  • Univer Of Illinois at Chicago, Chicago
  • Eagle Clinical Research, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07567001

Digital InteGrated Behavioral treatmeNt for Comorbid obesITy and deprEssion Among Racial and Ethnic Adults Age 50 and Older

Ap rekrite
  • Department of Medicine, Vitoux Program on Aging and Prevention, Chicago
Laj 50 a 74 · Tout sèks · Mizajou Aug 18, 2026 · NCT06636058

Role of Adiposomes in Endothelial Dysfunction

Ap rekrite
  • University of Illinois at Chicago, Chicago
Laj 18 a 50 · Tout sèks · Mizajou Aug 17, 2026 · NCT05199454

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Ap rekriteFaz 3
  • ACCOMPLISH-1 Research Site, Chicago
Laj 18 a 79 · Tout sèks · Mizajou Aug 10, 2026 · NCT07654361

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

Ap rekrite
  • Jesse Brown VA Medical Center, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT06390345

FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control

Ap rekriteFaz 2
  • Mile Square Health Center Chicago, Chicago
  • Mile Square Health Center - Auburn Gresham, Chicago
  • Mile Square Health Center - Englewood, Chicago
  • ak 1 plis
Tout laj · Tout sèks · Mizajou Jul 10, 2026 · NCT07332741

Better Lifestyle Counseling for African American Women During Pregnancy

Ap rekrite
  • University of Illinois at Chicago, Chicago
  • University of Illinois at Chicago, Chicago
Laj 18 a 40 · Fanm · Mizajou Jul 9, 2026 · NCT05234125

PRImary Care Strategies for Weight Management (PRISM) Study

Ap rekrite
  • Rush University Medical Center, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Jul 9, 2026 · NCT07288294

Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients

Ap rekrite
  • Prentice Women's Hospital, Chicago
Laj 18 ak plis · Fanm · Mizajou May 26, 2026 · NCT06466161

Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors

Ap rekrite
  • Northwestern University-Feinberg School of Medicine, Chicago
Laj 18 ak plis · Tout sèks · Mizajou May 8, 2026 · NCT05687604

EAT: A Reliable Eating Assessment Technology for Free-living Individuals

Ap rekriteVolontè an sante akeyi
  • Northwestern University, Chicago
Laj 18 ak plis · Tout sèks · Mizajou May 7, 2026 · NCT06118528

RemI for Post-Bariatric Surgery Weight Regain

Ap rekriteVolontè an sante akeyi
  • Rush University, Chicago
Laj 18 a 70 · Tout sèks · Mizajou Apr 3, 2026 · NCT06292936

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

Ap rekriteEtid obsèvasyon
  • Northwestern Memorial Hospital, Chicago
Laj 18 a 70 · Tout sèks · Mizajou Mar 17, 2026 · NCT07207148

Predictors of Behavioral Obesity Treatment Outcomes

Ap rekriteVolontè an sante akeyi
  • Rush University Medical Center, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Mar 11, 2026 · NCT05326477

A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment

Ap rekriteFaz 1/2Volontè an sante akeyi
  • Ann and Robert H. Lurie Children's Hospital of Chicago (Part C and Part D), Chicago
Laj 12 a 65 · Tout sèks · Mizajou Dec 22, 2025 · NCT06239116

Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

Ap rekriteFaz 3
  • University of Chicago, Chicago
Laj 18 a 75 · Tout sèks · Mizajou Nov 14, 2025 · NCT06499857

Preparing FIM-BCS - A Lifestyle Modification for African-American Breast Cancer Survivors

Ap rekrite
  • University of Illinois Chicago, Chicago
Laj 18 a 99 · Fanm · Mizajou Nov 10, 2025 · NCT06504914

DNA Methylation and Vascular Function

Ap rekriteVolontè an sante akeyi
  • University of Illinois at Chicago, Chicago
Laj 18 a 50 · Tout sèks · Mizajou Sep 15, 2025 · NCT03527420

Etid Obèsite nan lòt vil

Lòt etid nan Chicago

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.